Mercer Global Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.25M Buy
18,523
+3,462
+23% +$1.54M 0.02% 413
2025
Q1
$7.3M Buy
15,061
+1,053
+8% +$511K 0.02% 449
2024
Q4
$5.64M Sell
14,008
-1,543
-10% -$621K 0.01% 512
2024
Q3
$7.3M Sell
15,551
-952
-6% -$447K 0.02% 399
2024
Q2
$7.7M Buy
16,503
+3,106
+23% +$1.45M 0.02% 358
2024
Q1
$5.6M Sell
13,397
-1,119
-8% -$468K 0.02% 433
2023
Q4
$5.91M Buy
14,516
+2,789
+24% +$1.13M 0.02% 421
2023
Q3
$4.08M Buy
11,727
+713
+6% +$248K 0.02% 486
2023
Q2
$3.88M Buy
11,014
+899
+9% +$316K 0.02% 519
2023
Q1
$3.19M Buy
10,115
+1,821
+22% +$574K 0.01% 553
2022
Q4
$2.4M Buy
8,294
+170
+2% +$49.1K 0.01% 648
2022
Q3
$2.35M Sell
8,124
-835
-9% -$242K 0.01% 590
2022
Q2
$2.53M Sell
8,959
-1,127
-11% -$318K 0.02% 552
2022
Q1
$2.63M Buy
10,086
+613
+6% +$160K 0.02% 566
2021
Q4
$2.08M Buy
9,473
+2,251
+31% +$494K 0.01% 608
2021
Q3
$1.31M Buy
7,222
+814
+13% +$148K 0.01% 762
2021
Q2
$1.29M Sell
6,408
-11,397
-64% -$2.3M 0.01% 735
2021
Q1
$3.83M Buy
17,805
+12,652
+246% +$2.72M 0.03% 354
2020
Q4
$1.22M Sell
5,153
-1,651
-24% -$390K 0.02% 551
2020
Q3
$1.85M Buy
6,804
+687
+11% +$187K 0.03% 405
2020
Q2
$1.78M Buy
6,117
+4,667
+322% +$1.36M 0.03% 352
2020
Q1
$345K Sell
1,450
-47
-3% -$11.2K 0.01% 766
2019
Q4
$328K Sell
1,497
-10
-0.7% -$2.19K 0.01% 882
2019
Q3
$255K Buy
1,507
+49
+3% +$8.29K 0.01% 946
2019
Q2
$267K Buy
1,458
+29
+2% +$5.31K 0.01% 923
2019
Q1
$263K Buy
+1,429
New +$263K 0.01% 868